150 related articles for article (PubMed ID: 2195551)
1. Enhancement of the antitumor effects of 5-fluorouracil by folinic acid.
Mini E; Trave F; Rustum YM; Bertino JR
Pharmacol Ther; 1990; 47(1):1-19. PubMed ID: 2195551
[TBL] [Abstract][Full Text] [Related]
2. Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia.
Mini E; Coronnello M; Carotti S; Gerli A; Pesciullesi A; Moroson BA; Mazzei T; Periti P; Bertino JR
J Chemother; 1990 Feb; 2 Suppl 1():17-27. PubMed ID: 2142214
[TBL] [Abstract][Full Text] [Related]
3. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
5. [The biochemical modulation of 5-fluorouracil by leucovorin].
Borner M; Brunner K
Schweiz Med Wochenschr; 1991 Aug; 121(33):1149-56. PubMed ID: 1925442
[TBL] [Abstract][Full Text] [Related]
6. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Fujiwara Y; Saijo N
Cancer Chemother Pharmacol; 1992; 30(6):417-22. PubMed ID: 1327567
[TBL] [Abstract][Full Text] [Related]
7. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas.
Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ
Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503
[TBL] [Abstract][Full Text] [Related]
8. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid.
Machover D; Zittoun J; Broët P; Metzger G; Orrico M; Goldschmidt E; Schilf A; Tonetti C; Tan Y; Delmas-Marsalet B; Luccioni C; Falissard B; Hoffman RM
Biochem Pharmacol; 2001 Apr; 61(7):867-76. PubMed ID: 11274973
[TBL] [Abstract][Full Text] [Related]
10. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
Morgan RG
Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
Allegra CJ; Chabner BA; Sholar PW; Bagley C; Drake JC; Lippman ME
NCI Monogr; 1987; (5):199-202. PubMed ID: 3501543
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil].
Iba T; Yagi Y; Kidokoro A; Fukunaga T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):479-83. PubMed ID: 8452385
[TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Correlation of antitumor activity with dosage and FUra incorporation into RNA.
Nord LD; Stolfi RL; Martin DS
Biochem Pharmacol; 1992 Jun; 43(12):2543-9. PubMed ID: 1378737
[TBL] [Abstract][Full Text] [Related]
14. Biochemical rationale for the 5-fluorouracil leucovorin combination and update of clinical experience.
Rustum YM
J Chemother; 1990 Feb; 2 Suppl 1():5-11. PubMed ID: 2195138
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
[TBL] [Abstract][Full Text] [Related]
16. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
Erlichman C; Mitrovski B
Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P; Bertino JR
Biochem Pharmacol; 1987 Sep; 36(18):2905-11. PubMed ID: 2958010
[TBL] [Abstract][Full Text] [Related]
19. Antitumour effects of pure diastereoisomers of 5-formyltetrahydrofolate in hepatic transplants of a rodent colon carcinoma model.
Carlsson G; Gustavsson B; Frösing R; Odin E; Hafström LO; Spears CP; Larsson PA
Biochem Pharmacol; 1995 Oct; 50(9):1347-51. PubMed ID: 7503782
[TBL] [Abstract][Full Text] [Related]
20. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
